AT7519 TFA
AT7519 is a potent, multi-target cyclin-dependent kinase (CDK) inhibitor with IC50 values ranging from 0.018 to 0.66 μM against CDK1, CDK2, CDK4, CDK5, and CDK6. It is widely used in cancer research to study cell cycle arrest and apoptosis, demonstrating antitumor activity in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1431697-85-6
Field of Research
Cell Biology, Immunology & Inflammation
Smiles
OC (=O) C (F) (F) F.Clc1cccc (Cl) c1C (=O) Nc1c[nH]nc1C (=O) NC1CCNCC1
Molecular Formula
C18H18Cl2F3N5O4
Molecular Weight
496.27
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
LCORL-5014M 50 µg
Recombinant Mouse LCORL Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details MBS042688 Inquire
Cavy Perinuclear Neutrophil Cytoplasmic Antibody ELISA Kit
Sign In for Pricing
View Details